RASAL2 activates RAC1 to promote triple-negative breast cancer progression
Cited by 86
Related Papers
IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel
|Nature Communications|2015|170
Stromal induction of BRD4 phosphorylation Results in Chromatin Remodeling and BET inhibitor Resistance in Colorectal Cancer
|Nature Communications|2021|115
HIFI-α activation underlies a functional switch in the paradoxical role of Ezh2/PRC2 in breast cancer
|Proceedings of the National Academy of Sciences|2016|90
Apoptosis Signal-regulating Kinase 1 Is a Direct Target of E2F1 and Contributes to Histone Deacetylase Inhibitorinduced Apoptosis through Positive Feedback Regulation of E2F1 Apoptotic Activity
|Journal of Biological Chemistry|2006|63
EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy
|Nature Communications|2020|54